INTRODUCTION
============

Acute kidney injury (AKI) is a common problem in many clinical settings including renal transplantation. Because of many limitations, indicators such as serum creatinine or urinary output are not reliable for early diagnosis of deteriorating renal function. A biomarker to facilitate prediction of kidney function would be valuable. Based on published articles, it seems that urinary and plasma neutrophil gelatinase-associated lipocalin (NGAL), are reliable biomarkers for the subsequent development of clinical AKI. However, there is not a consensus on this biomarker for prediction of graft dysfunction after transplantation \[[@B1]-[@B4]\].

Belonging to the lipocalin superfamily, NGAL, a 25-kDa protein was initially found in activated neutrophils. However, other cells, such as renal tubular cells, may release NGAL in response to inflammation or injury \[[@B5],[@B6]\].

In a meta-analysis of 19 studies with 2538 patients, it has been documented that NGAL level increases in urine and/or plasma before clinical diagnosis of AKI with prognostic significance; it has also been shown to be a useful indicator to predict renal replacement therapy initiation and in-hospital mortality \[[@B7]\].

In kidney transplantation, Mishra, *et al*., examined 25 specimens of kidneys biopsies obtained at approximately one hour of reperfusion after transplantation for NGAL expression by immunohistochemistry and found a strong correlation between NGAL expression not only with cold ischemia time (r=0.87, p\<0.001) but also with peak post-operative creatinine level days later (r=0.86, p\<0.001) \[[@B3]\]. NGAL level in post-transplantation period has positive correlation with serum creatinine; the first day urinary NGAL predicts dialysis need within the first week of transplantation better than serum creatinine \[[@B2],[@B8],[@B9]\] Hollman, *et al*., in their study on 176 kidney recipients, also showed slower decrease in urinary NGAL compared to those without delayed graft function (DGF); urinary NGAL of the first post-transplantation day predicted DGF even when the clinicians did not expect which reflects the prognostic value of NGAL in these patients \[[@B10]\]. The value of NGAL was even highlighted in prediction of early functional recovery of transplanted kidneys from cardiac death donors in comparison with living donors \[[@B11]\].

The objective of this study was to re-evaluate the predictive value of serum NGAL in predicting DGF in kidney transplantation and figure out the best time for measurement of NGAL.

PATIENTS AND METHODS
====================

This prospective observational study was performed on 33 renal allograft recipients who received their kidneys in Imam Hospital, Tehran, Iran, from March 2010 to September 2010. The immunosuppressive regimen consisted of cyclosporine, mycophenolate mofetil, and prednisolone. The protocol of this study was approved by the Medical University Ethics Committee. Serum NGAL (Antibodyshop, Gentofte, Denmark) and creatinine, hemoglobin, blood glucose (commercially available kits) and urine output were measured at 0, 12, 24, 36, 48 and 72 hours after transplantation. Serum creatinine was measured by Jaffé method. Routinely, all patients underwent renal scintigraphy on the second day after operation. Measurements were performed by hospital laboratory personnel who were not aware of the NGAL source.

We used the definition of Hall, *et al*, for DGF *(i.e.,* need to dialysis in the first week of transplantation), slow graft function (SGF, *i.e.*, reduction in serum creatinine on day seven to the time of transplantation \<70%), and immediate graft function (IGF, *i.e.*, \>70% reduction of serum creatinine on seventh day in comparison with transplantation time) \[[@B12]\].

Statistical analysis

Data were expressed as mean±SD (range). One-way analysis of variance (ANOVA) was used to assess the level of plasma NGAL at different hours in three levels of graft function. Kruskall-Wallis test was used to determine if the difference in cause of renal failure, sex of donor or recipient had any impact on renal function after transplantation. Repeated-measures ANOVA was used for plasma NGAL and creatinine levels at different time points. Correlations between NGAL and other variables were evaluated by Pearson's or Spearman's correlation coefficients, as appropriate. Receiver-operating characteristic (ROC) curve was used to determine the cutoff point for plasma NGAL level to predict DGF. All tests were two-sided; p\<0.05 was considered statistically significant.

RESULTS
=======

The study was conducted on 33 kidney recipients. There were 16 men and 17 women. The mean±SD age of participants was 36.3±12.2 (range: 14--58) years. In 12 (36%) patients the cause of end-stage renal disease (ESRD) was unknown. Hypertension and diabetes were the cause in 11 (33%) and 4 (12%) patients, respectively. Four (12%) patients had preemptive transplantation and the rest had history of dialysis. The source of kidney was from brain-dead donors (BDD) in 20 (61%) patients.

Twenty-seven (82%) patients were prescribed polyclonal antibodies during induction therapy. The demographic data are shown in different groups in [Table 1](#T1){ref-type="table"}.

###### 

Recipients and donors characteristics

  -------------------------------------------------------------------------------------------------------------------------------------
  Parameter                                                 All (n=33)            DGF (n=6)      SGF (n=8)      IGF (n=19)    p value
  --------------------------------------------------------- --------------------- -------------- -------------- ------------- ---------
  Source of kidney                                                                                                            0.60

  BDD\                                                      20\                   3\             6\             11\           
  LD                                                        13                    3              2              8             

  Mean±SD (range) recipient age (yr)\                       36.3±12.2 (14--58)\   36.0±12.7\     37.9±14.3\     35.5±11.7\    0.89
  BDD\                                                      36±12.7\              29.0±9.5\      39.2±15.1\     36.2±12.4\    
  LD                                                        36.8±11.9             43.7±8.0       35.0±21.2      34.6±11.5     

  Recipient sex (M/F)\                                      10/10\                2/3\           4/5\           10/9\         0.15
  BDD\                                                      6/7                   2/1            1/5            7/4           
  LD                                                                                                                          

  ESRD due to DM\                                           2/20\                 1/6\           1/7\           2/17\         0.92
  BDD\                                                      2/13                  0\             1\             1\            
  LD                                                                              1              0              1             

  Mean±SD daily urine volume before transplantation (mL)\   197.5±334.2\          220±438\       267±346.4\     57.9±139.7\   0.15
  BDD\                                                      50±86.6               333.3±577.4\   350.0±393.7\   77.3±180.8\   
  LD                                                                              133.3±152.8    0              31.3±45.8     

  Dialysis before transplantation (yes/no)\                 16/4\                 5/0\           6/3\           18/1\         0.84
  BDD\                                                      13/0                  3/0\           3/3\           10/1\         
  LD                                                                              3/0            2/0            8/0           

  Mean±SD hemodialysis duration (m)\                        30.2±31.7\            50.7±58.8      15.8±17.8      29.9±21.6     0.12
  BDD\                                                      30.2±36.7\                                                        
  LD                                                        30.3±23.2                                                         

  Donor sex (M/F)\                                          16/4\                 4/1\           7/2\           16/3\         0.40
  BDD\                                                      11/2                  2/1\           4/2\           10/1\         
  LD                                                                              3/0            2/0            6/2           

  Mean±SD donor age (yr)\                                   27.9±9.0 (16--55)\    30.7±8.4       34.8±12.1      24.1±5.3      0.009
  BDD\                                                      29.25±11.1\                                                       
  LD                                                        25.77±3.47                                                        

  Polyclonal antibodies (yes/no)\                           27\                   6/0\           5/3\           16/3\         0.276
  BDD (yes)\                                                18\                   3\             4\             11\           
  LD (yes)                                                  9                     3              1              5             

  Mean±SD (range) cold ischemia time (min)\                 58±54 (10--240)\      46.7±42.6      73.1±52.8      55.3±58.8     0.64
  BDD\                                                      84.25±55\                                                         
  LD                                                        17.7±8.80                                                         

  Mean±SD warm ischmia time (min)\                                                105.0±231.5    128.8±37.2     97.9±22       0.05
  BDD\                                                                                                                        
  LD                                                                                                                          
  -------------------------------------------------------------------------------------------------------------------------------------

Serum NGAL level did not show significant difference between sex of recipients or history of hypertension/diabetes. It also did not have any correlation in separate analysis of BDD and LD recipients, with cold and warm ischemia time. At each time, serum NGAL was correlated positively to serum creatinine level. Serum NGAL level on the first day and its rate of decrease after transplantation were significantly different among the studied groups (p=0.014 and 0.003, respectively); however, it was not significantly different among the groups before transplantation. The serum level of NGAL after 12 hours of transplantation had a significant (p\<0.001) correlation with renal scan findings; the level after the operation correlated negatively with urine volume during the same period (r = 0.34, p=0.05). Serum creatinine level after 48 hours of transplantation had significant predictive value for kidney function (24 hrs, p=0.15; 48 hrs, p=0.04).

###### 

Comparison of kidney function recovery during post-transplantation period. Numbers are mean±SD.

  -------------------------------------------------------------------------
  Marker       DGF (n=5)        SGF (n=9)        IGF (n=19)       p value
  ------------ ---------------- ---------------- ---------------- ---------
  NGAL0\       6500±1542.7\     4255.6±2631.1\   3826.3±2650.7\   0.125\
  Creat0       7.3±1.0          5.5±1.9          7.2±1.5          0.29

  NGAL12\      4580.0±2507.4\   3644.4±2112.0\   2684.2±1962.0\   0.170\
  Creat12      6.1±1.3          4.2±1.6          5.0±1.5          0.74

  NGAL24\      4120.0±2232.0\   3011.1±1832.6\   1721.1±1387.1\   0.014\
  Creat24      5.6±1.2          3.6±1.4          3.9±1.1          0.15

  NGAL48\      3360.0±2250.1\   2300.0±1572.4\   1205.8±889.2\    0.007\
  Creat48      4.1±1.9          2.8±1.3          2.5±0.8          0.04

  NGAL72\      2916.0±2147.6\   2067.8±1523.6\   736.8±618.3\     0.001\
  Creat72      3.5±1.9          2.4±1.1          1.7±0.7          0.04

  Ratio\       0.66±0.23\       0.86±0.15\       0.71±0.15\       0.06\
  NGAL 12/0\   0.83±0.1         0.78±0.1         0.70±0.1         0.05
  Creat 12/0                                                      

  Ratio\       0.59±0.23\       0.70±0.24\       0.45±0.13\       0.003\
  NGAL 24/0\   0.77±0.15        0.65±0.1         0.55±0.13        0.005
  Creat 24/0                                                      
  -------------------------------------------------------------------------

Urine output after operation had a significant negative correlation with creatinine level at 12, 24, 48 and 72 hours of transplantation; however, its negative correlation lasts till 24 hours after transplantation with serum NGAL level. At any time, serum NGAL, and creatinine levels were significantly higher among patients with DGF and SGF compared with those with IGF (p=0.024 and 0.026, respectively). However, when they were compared between those who got IGF *vs*. non-IGF, serum creatinine levels were not significantly different (p=0.59) and serum NGAL levels differed significantly (p=0.02).

In order to assess the predictive value of NGAL *vs*. creatinine for DGF or non-IGF (combined DGF or SGF) we compared the areas under the ROC curves (AUCs) ([Table 3](#T3){ref-type="table"}). Serum NGAL or serum creatinine on the first post-transplantation day had similar AUC and predictive value to predict the patient's need to dialysis in the first week. However, using the AUCs of serum creatinine was not helpful in comparison with serum NGAL for predicting non-IGF. The AUCs of the serum NGAL were 0.70 (95% CI: 0.52--0.89) after 12 hours and 0.76 (95% CI: 0.59--0.93) after 24 hours (p\<0.05). The highest AUC was attributed to serum NGAL of 24 hours (0.82, p=0.002) ([Fig. 1](#F1){ref-type="fig"}).

###### 

ROC of NGAL and creatinine levels to predict DGF or non-IGF

  -----------------------------------------------------------------------------------
  Marker *vs* time   DGF                  Non-IGF                          
  ------------------ -------------------- ----------- -------------------- ----------
  After operation\   0.80 (0.66--0.94)\   0.02^\*^\   0.68 (0.50--0.87)\   0.08\
  NGAL (ng/mL)\      0.82 (0.65--1.00)\   0.08\       0.34 (0.13--0.54)    0.11
  -BDD\              0.88 (0.69--1.08)\   0.05\                            
  -LD\               0.53 (0.30--0.76)    0.85                             
  Creat                                                                    

  12 hours\          0.74 (0.55--0.92)\   0.08\       0.70 (0.52--0.89)\   0.05\*\
  NGAL\              0.82 (0.64--1.01)\   0.08\       0.49 (0.27--0.70)    0.89
  -BDD\              0.73 (0.46--1.00)\   0.24\                            
  -LD\               0.71 (0.50--0.92)    0.11                             
  Creat                                                                    

  24 hours\          0.80 (0.59--1.0)\    0.02\*\     0.76 (0.59--0.93)\   0.01\*\
  NGAL\              0.87 (0.70--1.04)\   0.04\*\     0.54 (0.32--0.75)    0.73
  -BDD\              0.78 (0.41--1.15)\   0.15\                            
  -LD\               0.80 (0.61--0.99)    0.03\*                           
  Creat                                                                    

  48 hours\          0.85 (0.68--1.0)\    0.009\*\    0.78 (0.61--0.94)\   0.007\*\
  NGAL\              0.92 (0.79--1.05)\   0.02\*\     0.63 (0.41--0.84)    0.22
  -BDD\              0.82 (0.54--1.09)\   0.11\                            
  -LD\               0.80 (0.55--1.1)     0.02\*                           
  Creat                                                                    

  72 hours\          0.83 (0.61--1.0)\    0.01\*\     0.82 (0.65--0.98)\   0.002\*\
  NGAL\              0.92 (0.79--1.05)\   0.02\*\     0.70 (0.50--0.90)    0.05
  -BDD\              0.77 (0.37--1.16)\   0.18\                            
  -LD\               0.82 (0.55--1.1)     0.02\*                           
  Creat                                                                    
  -----------------------------------------------------------------------------------

LRD: Living related donor; LURD: Living unrelated donor
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AUCs for predicting DGF and non-IGF using serum creatinine on the first post-operative day were 0.80 (95% CI: 0.61--0.99) and 0.54 (95% CI: 0.32--0.75), respectively.

DISCUSSION
==========

Diagnosis of acute graft dysfunction is usually made with increased serum creatinine concentration, which is a late signal of kidney injury. Nevertheless, the sooner treatment is initiated the better outcome is expected. The treatment should be as close as possible to the insult just before the diagnosis is made by serum creatinine \[[@B13]\].

Our study, like other studies, confirmed that plasma NGAL level was more useful than absolute or percentage of serum creatinine decrease in predicting DGF \[[@B7],[@B9],[@B11],[@B12]\]. However, plasma NGAL level before with first 24 hours of transplantation was not able to differentiate patients with DGF from those with non-DGF. In this study, we found that the best time for measuring plasma NGAL level for such purpose is 24 hours after the transplantation. Similar to Lebkowska, *et al*., we found a significant decrease in serum NGAL as early as one day after transplantation---before the serum creatinine level decreases \[[@B2]\]. Bataille, *et al*., in 41 transplant patients found an early and significant post-operative decrease in plasma NGAL after 12 hours of transplantation in the IGF group, which remained elevated in the DGF group throughout the follow-up period \[[@B14]\]. Similar to our study, they showed that the decrease in creatinine level was delayed compared with plasma NGAL decrease.

Mishra, *et al*., found the highest NGAL staining intensity in biopsies of one hour of reperfusion after transplantation in those with DFG \[[@B3]\]. Although plasma NGAL level after transplantation was highest in DGF group, surprisingly, no significant correlation was observed between NGAL and DGF, which may be due to limited sample size or its excretion into the urine rather than being released into the circulation. It was shown that the urine output after operation negatively correlated with plasma NGAL after operation which supports the explanation.

The main limitation of our study was the small sample size (20 from BDD) for which we could not do subgroup analysis. However, based on prior studies, the results support the finding that plasma NGAL level, especially after 24 hours of transplantation, is an early accurate predictor of both the need to dialysis and slow graft function within the first week of kidney transplantation.
